Context Capital Management, LLC - CLARUS THERAPEUTICS HLDNGS I ownership

Back to all holdings Add to watchlist

CLARUS THERAPEUTICS HLDNGS I's ticker is and the CUSIP is 18271L115. A total of 25 filers reported holding CLARUS THERAPEUTICS HLDNGS I in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
Context Capital Management, LLC ownership history of CLARUS THERAPEUTICS HLDNGS I
ValueSharesWeighting
Q3 2022$0
-100.0%
62,1750.0%0.00%–
Q2 2022$5,000
-44.4%
62,1750.0%0.00%
-100.0%
Q1 2022$9,000
-64.0%
62,175
-28.7%
0.00%
-50.0%
Q4 2021$25,000
-71.6%
87,175
-25.7%
0.00%
-77.8%
Q3 2021$88,000–117,311–0.01%–
 Download
Other shareholders
CLARUS THERAPEUTICS HLDNGS I shareholders Q3 2021
NameSharesValueWeighting ↓
Tower Research Capital LLC (TRC) 91$00.00%
NOMURA HOLDINGS INC 85,000$00.00%
Context Capital Management, LLC 62,175$00.00%
MIZUHO SECURITIES USA LLC 100,000$1,0000.00%
Caption Management, LLC 140,821$00.00%
View complete list of CLARUS THERAPEUTICS HLDNGS I shareholders